Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

LRP8-Reelin-Regulated Neuronal Enhancer Signature Underlying Learning and Memory Formation.

Neuron | 2015

One of the exceptional properties of the brain is its ability to acquire new knowledge through learning and to store that information through memory. The epigenetic mechanisms linking changes in neuronal transcriptional programs to behavioral plasticity remain largely unknown. Here, we identify the epigenetic signature of the neuronal enhancers required for transcriptional regulation of synaptic plasticity genes during memory formation, linking this to Reelin signaling. The binding of Reelin to its receptor, LRP8, triggers activation of this cohort of LRP8-Reelin-regulated neuronal (LRN) enhancers that serve as the ultimate convergence point of a novel synapse-to-nucleus pathway. Reelin simultaneously regulates NMDA-receptor transmission, which reciprocally permits the required γ-secretase-dependent cleavage of LRP8, revealing an unprecedented role for its intracellular domain in the regulation of synaptically generated signals. These results uncover an in vivo enhancer code serving as a critical molecular component of cognition and relevant to psychiatric disorders linked to defects in Reelin signaling.

Pubmed ID: 25892301 RIS Download

Associated grants

  • Agency: NINDS NIH HHS, United States
    Id: R01 NS034934
  • Agency: NCI NIH HHS, United States
    Id: R01 CA173903
  • Agency: NIDDK NIH HHS, United States
    Id: DK018477
  • Agency: NIGMS NIH HHS, United States
    Id: R01 GM104459
  • Agency: NIGMS NIH HHS, United States
    Id: GM104459
  • Agency: NIDDK NIH HHS, United States
    Id: R01 DK018477
  • Agency: NINDS NIH HHS, United States
    Id: NS034934
  • Agency: NIDDK NIH HHS, United States
    Id: R01 DK039949
  • Agency: NCI NIH HHS, United States
    Id: CA173903
  • Agency: Howard Hughes Medical Institute, United States
  • Agency: NIDDK NIH HHS, United States
    Id: R37 DK039949
  • Agency: NIDDK NIH HHS, United States
    Id: DK039949
  • Agency: NHLBI NIH HHS, United States
    Id: HL065445
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL065445

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


CRSP1/TRAP220 Antibody (antibody)

RRID:AB_577241

This unknown targets CRSP1/TRAP220

View all literature mentions

MEF2A-human (antibody)

RRID:AB_631920

This polyclonal targets MEF2A

View all literature mentions

Anti-GAPDH Antibody (G-9) (antibody)

RRID:AB_10847862

This monoclonal targets GAPDH

View all literature mentions

p-CaMKII (22B1) (antibody)

RRID:AB_626786

This monoclonal targets Rat CaMKII, phospho (Thr286)

View all literature mentions

MED23 Antibody (antibody)

RRID:AB_2142302

This unknown targets MED23

View all literature mentions

Rabbit Anti-ChIPAb+? Phospho-CREB (Ser133) Polyclonal Antibody, Unconjugated (antibody)

RRID:AB_10807817

This polyclonal targets Rabbit ChIPAb+? Phospho-CREB (Ser133)

View all literature mentions

H4K16ac-celegans (antibody)

RRID:AB_310525

This polyclonal targets H4K16ac

View all literature mentions

MEF2C antibody (antibody)

RRID:AB_2250564

This polyclonal targets Mef2c

View all literature mentions

H3K27ac-human (antibody)

RRID:AB_2118291

This polyclonal targets H3K27ac

View all literature mentions

CREBBP-human (antibody)

RRID:AB_303342

This polyclonal targets CREBBP

View all literature mentions

ApoER2 antibody [EPR3326] (antibody)

RRID:AB_10862841

This monoclonal targets ApoER2 antibody [EPR3326]

View all literature mentions